BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 62 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,429 | -18.8% | 31,182 | 0.0% | 0.00% | – |
| Q2 2023 | $39,913 | -7.9% | 31,182 | 0.0% | 0.00% | – |
| Q1 2023 | $43,343 | +3.3% | 31,182 | -3.4% | 0.00% | – |
| Q4 2022 | $41,963 | -12.6% | 32,279 | 0.0% | 0.00% | – |
| Q3 2022 | $48,000 | +9.1% | 32,279 | +51.0% | 0.00% | – |
| Q2 2022 | $44,000 | -91.4% | 21,372 | -88.5% | 0.00% | – |
| Q1 2022 | $510,000 | -46.6% | 186,184 | -4.5% | 0.00% | – |
| Q4 2021 | $955,000 | -59.6% | 194,893 | +4.3% | 0.00% | – |
| Q3 2021 | $2,362,000 | +29.1% | 186,780 | +57.8% | 0.00% | – |
| Q2 2021 | $1,829,000 | -58.4% | 118,365 | -11.4% | 0.00% | -100.0% |
| Q1 2021 | $4,396,000 | – | 133,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hawkeye Capital Management, LLC | 415,039 | $431,641 | 1.06% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1,213,630 | 0.98% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1,967,126 | 0.78% |
| TANG CAPITAL MANAGEMENT LLC | 3,557,040 | $3,699,322 | 0.52% |
| Vivo Capital, LLC | 3,871,291 | $4,026,143 | 0.44% |
| Samsara BioCapital, LLC | 1,049,153 | $1,091,119 | 0.33% |
| Acuitas Investments, LLC | 460,379 | $478,794 | 0.28% |
| Newtyn Management, LLC | 1,020,000 | $1,060,800 | 0.26% |
| Sofinnova Investments, Inc. | 2,754,437 | $2,864,614 | 0.18% |
| Privium Fund Management (UK) Ltd | 116,516 | $121,177 | 0.10% |